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ORIGINAL ARTICLE
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Yoo-Bin Kwon, M.S., Kyung-Cheol Sohn, Ph.D., Myung Im, M.D., Young Joon Seo, M.D., 
Jeung Hoon Lee, M.D.
Department of Dermatology, College of Medicine, Chungnam National University, Daejeon, Korea
Background:  Aquaporins (AQPs) are a family of water 
transporting proteins present in many mammalian epithelial 
and endothelial cell types. Among the AQPs, AQP3 is known 
to be a water/glycerol transporter expressed in human skin. 
Objective: The relationship between the expression level of 
AQP3 and transpidermal water loss (TEWL) in the lesional 
and peri-lesional skin of psoriasis-affected patients, and skin 
hydration in the lesional and peri-lesional skin of psoriasis 
patients, was investigated. Methods: The expression of 
AQP3 in psoriasis-affected and healthy control skin was 
determined using immunohistochemical and immunofluro-
scence staining. TEWL and skin hydration were measured 
using a Tewameter
Ⓡ TM210 (Courage & Khazaka, Cologne, 
Germany) and a Corneometer
Ⓡ CM 820 (Courage & 
Khazaka), respectively. Results: AQP3 was mainly expressed 
in the plasma membrane of stratum corneum and the stratum 
spinosum in normal epidermis. Unlike the normal epidermis, 
AQP3 showed decreased expression in the lesional and 
peri-lesional epidermis of psoriasis. TEWL was increased, 
and skin hydration was decreased, in the lesional and 
peri-lesional skin of psoriasis patients, compared with the 
healthy control sample. Conclusion: Although various fac-
tors contribute to reduced skin hydration in the lesional and 
peri-lesional skin of psoriasis, AQP3 appears to be a key 
factor in the skin dehydration of psoriasis-affected skin. (Ann 
Dermatol 24(2) 168∼174, 2012)
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INTRODUCTION
Psoriasis is a chronic disease of the skin, characterized by 
erythematous plaques with thick scales. Patients with 
psoriasis usually complain of skin dryness. Avoiding skin 
dryness by appropriate use emollients helps prolong 
therapy-free intervals and aids in the prevention of early 
recurrence
1,2. Although there are many studies regarding 
the mechanisms involved in the skin dryness of atopic 
dermatitis, there are few studies relating specifically to 
psoriasis. 
Aquaporins (AQPs) are proteins that facilitate entry of 
water into cells and, currently, 13 family members have 
been identified in mammals. Unlike other AQPs, AQP3 is 
expressed in epithelial tissues and works as a water/ 
glycerol channel
3. The functional role of AQP3 in human 
epidermis is an area of current research interest, as AQP3 
is abundantly expressed in the basal and spinous layers of 
the epidermis. 
Recent studies have shown that AQP3 is not only involved 
in water transport and hydration in the human epidermis 
but also in the regulation of keratinocyte proliferation, cell 
migration, and tumorigenesis
4,5. Current studies of AQP3 
related to atopic dermatitis focus on skin dryness. How-Aquaporin-3 in Psoriasis
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ever, little is known about AQP3 expression in relation to 
skin hydration and transepidermal water loss (TEWL) in 
psoriatic skin lesions compared to healthy skin.
The aim of this study was to determine the expression of 
AQP3 in the epidermis of psoriasis and to investigate the 
relationship between AQP3 expression and skin hydration 
in psoriasis.
MATERIALS AND METHODS
Human subjects
A total of 5 patients with psoriasis and 5 healthy 
volunteers participated in this study for immunohisto-
chemical and immunofluorescent staining. A total of 19 
patients with psoriasis and 10 healthy volunteers partici-
pated for measurement of TEWL and skin hydration. None 
of the patients had received phototherapy or topical treat-
ments during the previous year. All skin samples were 
obtained under the written informed consent of donors, 
and the study was approved in accordance with the 
ethical committee approval process of Chungnam National 
University Hospital.
Cell culture
Normal human epidermal keratinocytes were cultured as 
previously reported
6. Keratinocytes were grown in a 
keratinocyte-serum-free medium supplemented with bovine 
pituitary extract and recombinant human epidermal 
growth factor (Invitrogen, Grand Island, NY, USA). 
Western blot analysis
Cells were lysed in Proprep solution (Intron). The total 
protein content was measured using a Bradford protein 
assay kit (Bio-Rad Laboratories, Hercules, CA, USA). 
Samples were run on sodium dodecyl sulfate-poly-
acrylamide gel, transferred onto nitrocellulose membranes, 
and incubated with appropriate antibodies. Blots were 
then incubated with peroxidase-conjugated secondary 
antibodies and visualized using enhanced chemilumi-
nescence (Intron). The following primary antibodies were 
used in this study: AQP3, AQP9, filaggrin, involucrin 
(Santa Cruz Biotechnologies, Santa Cruz, CA, USA), and 
actin (Sigma, St. Louis, MO, USA).
Immunofluorescence staining
Specimens were embedded in paraffin. Specimen sections 
were dewaxed, rehydrated, and washed three times in 
phosphate-buffered saline (PBS). After treatment with 
proteinase K (1 mg/ml), for 5 minutes at 37
oC, sections 
were treated with H2O2 for 10 minutes at room 
temperature, blocked in 0.1% Tween-20 and 1% bovine 
serum albumin in PBS for 20 minutes, and were allowed 
to react with appropriate primary antibodies for 4 hours. 
Sections were incubated sequentially with secondary 
antibody (anti-mouse IgG-TR, Santa Cruz Biotechnologies) 
and were observed and imaged under fluorescent 
microscopy (Olympus IX71). The fluorescence intensity 
was analyzed using an image analyzer (i-solution TM, 
iMTechnology, Bucheon, Korea)
Glycerol uptake analysis 
Normal human epidermal keratinocytes were cultured in 
serum free keratinocyte medium until 80% confluence, 
then starved in Keratinocyte- basal medium (KBM) for 1 
day. Cells were then incubated in KBM containing 1 
uCi/ml of [
3H]glycerol with and without 1.2 mM Ca
2+ for 
0 minute, 10 minutes, 30 minutes, 60 minutes, 4 hours, 
12 hours, 24 hours, and 48 hours. Reactions were stopped 
by washing twice with ice-cold PBS. Cells were 
subsequently solubilized in 1 N NaOH and aliquots of 
this extract were subjected to liquid scintillation counting. 
Counts obtained from duplicate samples at each time 
point for the two conditions were averaged and graphed, 
and a linear equation was determined for each condition. 
Correlation coefficients obtained were typically 0.99 or 
greater. Slopes determined from multiple experiments 
were averaged and analyzed statistically for significant 
differences between conditions
7.
TEWL and assessment of skin hydration 
To determine the moisture level of the skin surface, we 
performed TEWL and skin hydration measurements. 
Results were used to provide information regarding the 
status of the permeability barrier under normal, experi-
mentally perturbed, and diseased conditions. Published 
guidelines for the measurement of TEWL and skin 
hydration were followed. The condition of all subjects 
was first stabilized for 15 to 20 minutes, in a climate- and 
humidity-controlled room. The ambient temperature 
ranged between 21
oC and 24
oC, with a mean relative 
humidity range of 39∼50%. Two plaques on the arm 
were selected for study of lesional psoriatic skin, and 
normal appearing skin around the psoriatic plaques was 
selected as peri-lesional psoriatic skin. None of the 
selected psoriasis patients received phototherapy and 
topical treatment for at least the past year. The TEWL 
value was measured using a Tewameter
Ⓡ TM 210 
(Courage & Khazaka, Cologne, Germany) and skin 
hydration was measure using a Corneometer
Ⓡ CM 820 
(Courage & Khazaka)
8,9. Y Lee, et al
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Fig. 1. (A) Immunolocalization of aquaporins 3 (AQP3) uisng immunohistochemisty in the human epidermis. AQP3 is expressed in
the stratum basale and the stratum spinosum. (B) AQP3 expression in calcium-induced keratinocyte differentiation. AQP3 from cultured
keratinocyte extracts of 20 or 30 μg was loaded onto sodium dodecyl sulfate polyacrylamide gel electrophoresis and was detected 
using a peptide polyclonal anti-AQP3 antibody. Involucrin and filaggrin were used as control makers for differentiation. (C) The 
[
3H]glycerol uptake ability in calcium differentiated human keratinocytes. Near confluent keratinocytes were incubated in 
Keratinocyte-basal medium containing 1 uCi/ml of [
3H]glycerol with and without 1.2 mM Ca
2+ for 0 min, 10 min, 30 min, 60 min,
4 hr, 12 hr, 24 hr, and 48 hr. NHEK: normal human epidermal keratinocyte, CPM: counting per minute.
Statistical analysis
Statistical analysis was performed using SPSS ver.12.0 
(SPSS Inc., Chicago, IL, USA) for Windows. Results are 
presented as ± mean standard deviation. All experiments 
were repeated at least three times, with documented 
reproducibility. Data were analyzed for statistical signifi-
cance, using an independent t-test and repeated measures 
ANOVA. p-values of ＜0.05 were considered significant.
RESULTS
Expression of AQP3 in the normal human epidermis
To verify AQP3 protein expression in normal human 
epidermis, we performed immunofluorescent staining 
with an anti-AQP3 antibody. Fig. 1A shows abundant 
human epidermal AQP3 protein expression located in the 
keratinocyte plasma membrane of the stratum basale and 
stratum spinosum. AQP3 was weakly detected in the 
stratum granulosum and stratum corneum. 
To confirm the expression level of the AQP3 protein in 
the epidermis, we performed an immune blot analysis for 
calcium-induced keratinocyte differentiation. The immune Aquaporin-3 in Psoriasis
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Fig. 2. Aquaporins 3 (AQP3) immunoreactivity in (A) healthy control, (B) psoriatic lesional and (C) peri-lesional skin. AQP3 protein 
expression is decreased and mislocalized in lesional and peri-lesional skin, showing a diffuse cytoplasmic pattern. (D) AQP3 staining 
intensity between healthy control and psoriasis. The fluorescence intensity was analyzed using an image analyzer (i-solution TM, 
iMTechnology, Bucheon, Korea) *p<0.05 vs. healthy control. 
blot analysis showed that the AQP3 protein was expressed 
at the endogeneous level in normal epidermal keratino-
cytes, with a gradual decrease after 3 days. These results 
are similar to the immunofluorescent staining results (Fig. 
2).
Glycerol uptake in calcium differentiated human kera-
tinocytes
As AQP3 is known to participate in water/glycerol 
transport in the epidermis, the glycerol uptake in calcium 
differentiated keratinocytes was measured using radio-
labeled [
3H]glycerol for 48 hours. Fig. 1C shows a gradual 
increase in [
3H]glycerol uptake in calcium differentiated 
keratinocytes and a significant reduction in glycerol 
uptake after 48 hours. The [
3H]glycerol uptake reflects the 
results of AQP3 immunofluorescent and the immune blot 
analysis, which indicated AQP3 expression primarily in 
the malpighian layer. The glycerol uptake results illustrate 
the functional ability of AQP3, which is only expressed 
during early keratinocyte differentiation. These results are 
consistent with the location of AQP3 in the epidermis.
Expression of AQP3 in the skin of psoriasis
To identify AQP3 protein expression in the epidermis of 
psoriatic skin, we performed immunofluoresence staining 
with an anti-AQP3 antibody. Fig. 2 shows decreased 
expression of AQP3 in psoriatic lesional and peri-lesional 
skin, compared to the healthy control. The immuno-
reactivity patterns of AQP3 were different between the 
healthy control and psoriasis patients. The epidermis of 
healthy control patients showed AQP3 immunoreactivity 
localized largely in the plasma membrane of the Y Lee, et al
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Table 1. Comparison of skin hydration and TEWL between psoriasis patients and healthy controls
Psoriasis (n=19) Control (n=10) p-value
  Skin hydration (Corneometer®) units  Lesion  73.15±10.15  92.86±9.94  ＜0.001* 
Peri-lesion  83.91±11.7  92.86±9.94    0.049* 
Normal  90.31±11.11  92.86±9.94    0.548 
  TEWL (Tewameter®) g/hm
2 Lesion  13.52±4.41   9.75±1.11    0.002* 
Peri-lesion  12.41±3.83   9.75±1.11    0.010* 
Normal   9.47±2.89   9.75±1.11    0.710 
TEWL: transpidermal water loss. *p<0.05 vs. healthy control.
Fig. 3. (A) Differences in skin hydration among psoriatic lesional, peri-lesional, and normal non-psoriatic skin in psoriasis patients.
Skin hydration was measured using a Corneometer
Ⓡ CM 820 (Courage & Khazaka, Cologne, Germany). (B) Transpidermal water loss
(TEWL) differences among psoriatic lesional, peri-lesional, and normal non-psoriasis skin in psoriasis patients. TEWL was measured 
using a Tewameter
Ⓡ TM 210 (Courage & Khazaka).
malpighian layer, while psoriatic lesional and peri-lesional 
epidermis showed diffuse immunoreactivity localized to 
the cytoplasm rather than the plasma membrane.
TEWL and skin hydration in psoriasis and healthy 
control patients
For comparison of TEWL levels and skin hydration 
between psoriasis-affected (PA) and control patients, 
measurements were performed at least 5 times at each 
site. Measurements were made indoors, within a temper-
ature range 21∼24
oC and a relative humidity range of 39∼
50%. Psoriatic skin lesions were divided into the 3 groups 
of psoriasis lesional, psoriasis peri- lesional, and normal 
non-psoriasis skin. 
Table 1 shows the comparison between PA and control 
patients. Both psoriatic lesional and peri-lesional skin 
showed decreased skin hydration and increased TEWL 
levels, compared to healthy control skin. The skin hydra-
tion and TEWL levels of normal non-psoriatic skin of 
psoriasis patients did not differ from that of the control 
group. Fig. 3 shows skin hydration and TEWL values in 
psoriasis patients, divided into the three groups. Psoriasis 
lesions showed statistically significant decreased skin 
hydration and increased TEWL levels, compared to 
peri-lesional and normal non-psoriatic skin (p＜0.05). 
Psoriatic peri-lesional skin also showed statistically signifi-
cant decreased skin hydration and increased TEWL levels, 
compared with normal non-psoriatic skin; this suggests a 
defect in skin moisture in peri-lesional psoriasis, even 
when the skin appears normal (p＜0.05).
DISCUSSION
Psoriasis patients suffer not only from erythematous scaly 
plaques on the body but also from itching and dryness of 
the skin. Although there have been many studies investi-
gating the mechanism of epidermal hyperproliferation and 
immune cell activation in psoriasis, only a few explore 
potential reasons that skin lesions involved psoriasis are so 
dry
10. 
After the identification of AQP1 in 1993, 11 additional 
AQPs have been identified in mammals. AQPs have been 
described in epithelial cells of the skin, kidney, gastroin-
testinal, and respiratory tracts. The exact function of AQPs Aquaporin-3 in Psoriasis
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in the skin is less thoroughly investigated than in other 
organs but, recently, AQPs have attracted attention 
because AQP3 is abundantly expressed in the skin. 
The functional role of AQP3 in the skin had recently been 
demonstrated by the observed phenotype of AQP3 
knockout mice, which showed a reduced glycerol content, 
water holding capacity in the epidermis, decreased skin 
elasticity, and delayed wound healing
11,12. Moreover, a 
recent study showed decreased AQP3 expression in aging 
skin, suggesting that AQP3 is involved in the intrinsic 
aging of non sun-exposed human skin
13. 
AQP3 expression in the epidermis is localized in the 
keratinocyte plasma membrane in the stratum basale and 
stratum spinosum. The question arises of how AQP3 can 
function in stratum corneum hydration and TEWL when it 
is mainly located at the bottom of the epidermis. This is 
explained by a phenotype analysis of AQP3-deficient 
mice. In the study, high humidity and occlusion increased 
stratum corneum hydration in the wild-type, but not in 
AQP3 null mice. Skin conductance values for both the 
wild-type and AQP3 null mice were similar after exposure 
to 10% humidity, indicating that water transport via AQP3 
is not a rate-limiting factor in TEWL
10,11. Both water and 
glycerol permeability were significantly reduced in the 
epidermis of AQP3-knockout mice, with a normal 
concentration of glycerol in the dermis and the serum. 
Results suggest that there is reduced glycerol transport 
from the blood into the epidermis in the absence of 
AQP3, which is located in the malpighian layer of the 
epidermis, and that glycerol transport, rather than water 
transport, is responsible for stratum corneum hydration 
and TEWL, as glycerol is a natural moisturizing factor
14.
The AQP3 protein immunoreactivity patterns are different 
in psoriatic lesional and peri-lesional skin, compared to 
the healthy control skin. Not only is the immunoreactivity 
of AQP3 remarkably decreased in the lesional and 
peri-lesional skin of psoriasis, but the AQP3 protein is 
diffusely expressed in the cytoplasm rather than in the 
plasma membrane, as it is in the control group
15. AQP3 in 
psoriatic lesional and peri-lesional skin likely cannot 
function properly because the amount of the AQP3 
protein is reduced; AQP3 is also functionally impaired 
because of an abnormal localization in keratinocytes. The 
measurement of skin hydration and TEWL in psoriasis and 
healthy control patients indicated relevance to in vitro 
results suggesting a decrease in AQP3 protein expression 
in lesional and peri-lesional psoriasis skin, resulting in 
decreased skin hydration and increased TEWL. The cause 
of decreased AQP3 protein expression in psoriasis is 
unknown. However, there are studies indicating that 
tumor necrosis factor (TNF)-α  and TNF receptor-1 
signalling decreases AQP3 protein expression in some 
cells
16,17. Psoriasis is a Th1 cytokine dominant skin 
disorder, and TNF-α production is increased in kera-
tinocytes and infiltrated immune cells. This may be related 
to decreased AQP3 protein expression in psoriasis. The 
retinoic acid, which we use orally and topically in treating 
PA skin, is known to increase AQP3 expression in normal 
human skin
18. All-trans retinoic acid increased AQP3 
mRNA and protein expression in normal human 
epidermal keratinocytes, indicating that retinoic acid 
increases AQP3 expression and enhances biological 
activity in human skin.  We can hypothesize that using the 
retinoic acid in psoriasis can increase the expression of 
AQP3 in psoriasis epidermis, and AQP3 may play a 
functional role in improving psoriasis lesions, by 
regulating the keratinocyte proliferation and differentiation 
in psoriasis. 
In summary, AQP3 is the predominant AQP in the human 
epidermis, and decreased expression of AQP3 was 
identified in skin biopsies from lesional and peri-lesional 
psoriatic skin, compared to a healthy control. Skin hydra-
tion and TEWL measurements showed decreased skin 
hydration and increased TEWL in the lesional and peri- 
lesional skin of psoriasis, compared to a healthy control, 
indicating the relevance and significance of the associ-
ation with AQP3 expression in the epidermis. As AQP3 
functions as a water/glycerol transporter in skin, AQP3 
may be a key factor affecting decreased skin hydration and 
increased TEWL in psoriatic skin.
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